Capobianco C, Hankenson K, Knights A
Front Immunol. 2024; 15():1352819.
PMID: 38455063
PMC: 10917940.
DOI: 10.3389/fimmu.2024.1352819.
Borkowski L, Jojczuk M, Belcarz A, Pawlowska-Olszewska M, Kruk-Bachonko J, Radzki R
Materials (Basel). 2023; 16(17).
PMID: 37687681
PMC: 10488477.
DOI: 10.3390/ma16175992.
Chen N, Wu R, Lam Y, Chan W, Chan D
Bone Rep. 2023; 19:101698.
PMID: 37485234
PMC: 10359737.
DOI: 10.1016/j.bonr.2023.101698.
Zhang Q, Yang J, Hu N, Liu J, Yu H, Pan H
Bone Res. 2023; 11(1):40.
PMID: 37482549
PMC: 10363555.
DOI: 10.1038/s41413-023-00262-z.
Ng P, Ribet A, Guo Q, Mullin B, Tan J, Landao-Bassonga E
Nat Commun. 2023; 14(1):906.
PMID: 36810735
PMC: 9945426.
DOI: 10.1038/s41467-023-36484-2.
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation.
Kim A, Girgis C, McDonald M
Curr Osteoporos Rep. 2022; 20(6):505-515.
PMID: 36201122
PMC: 9718877.
DOI: 10.1007/s11914-022-00756-5.
Mitochondrial fatty acid β-oxidation is important for normal osteoclast formation in growing female mice.
Kushwaha P, Alekos N, Kim S, Li Z, Wolfgang M, Riddle R
Front Physiol. 2022; 13:997358.
PMID: 36187756
PMC: 9515402.
DOI: 10.3389/fphys.2022.997358.
Could BMPs Therapy Be Improved if BMPs Were Used in Composition Acting during Bone Formation in Endochondral Ossification?.
Hyc A, Osiecka-Iwan A, Moskalewski S
Int J Mol Sci. 2022; 23(18).
PMID: 36142232
PMC: 9499665.
DOI: 10.3390/ijms231810327.
Roles of osteoclasts in alveolar bone remodeling.
Omi M, Mishina Y
Genesis. 2022; 60(8-9):e23490.
PMID: 35757898
PMC: 9786271.
DOI: 10.1002/dvg.23490.
The Osteoclast Traces the Route to Bone Tumors and Metastases.
Russo S, Scotto di Carlo F, Gianfrancesco F
Front Cell Dev Biol. 2022; 10:886305.
PMID: 35646939
PMC: 9139841.
DOI: 10.3389/fcell.2022.886305.
Tyrosine Kinase Src Is a Regulatory Factor of Bone Homeostasis.
Matsubara T, Yasuda K, Mizuta K, Kawaue H, Kokabu S
Int J Mol Sci. 2022; 23(10).
PMID: 35628319
PMC: 9146043.
DOI: 10.3390/ijms23105508.
GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-κB and MAPK signaling pathways.
Tang C, Wang H, Zhang Y, Wang Z, Zhu G, McVicar A
Int J Biol Sci. 2022; 18(6):2392-2405.
PMID: 35414778
PMC: 8990458.
DOI: 10.7150/ijbs.70620.
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease.
Dow J, Simons M, Romero M
Nat Rev Nephrol. 2022; 18(7):417-434.
PMID: 35411063
DOI: 10.1038/s41581-022-00561-4.
Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects.
Li M, Jiang Y, Hou Q, Zhao Y, Zhong L, Fu X
Stem Cell Res Ther. 2022; 13(1):146.
PMID: 35379361
PMC: 8981790.
DOI: 10.1186/s13287-022-02822-2.
Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways.
Wang G, Ma C, Chen K, Wang Z, Qiu H, Chen D
Front Pharmacol. 2022; 12:810322.
PMID: 35126144
PMC: 8812338.
DOI: 10.3389/fphar.2021.810322.
The Role of TGF-β in Bone Metastases.
Trivedi T, Pagnotti G, Guise T, Mohammad K
Biomolecules. 2021; 11(11).
PMID: 34827641
PMC: 8615596.
DOI: 10.3390/biom11111643.
Engineered osteoclasts as living treatment materials for heterotopic ossification therapy.
Jin W, Lin X, Pan H, Zhao C, Qiu P, Zhao R
Nat Commun. 2021; 12(1):6327.
PMID: 34732696
PMC: 8566554.
DOI: 10.1038/s41467-021-26593-1.
Plasma Membrane Receptors Involved in the Binding and Response of Osteoclasts to Noncellular Components of the Bone.
Karanth D, Martin M, Holliday L
Int J Mol Sci. 2021; 22(18).
PMID: 34576260
PMC: 8466431.
DOI: 10.3390/ijms221810097.
Resorbable Mg-Containing Phosphates for Bone Tissue Repair.
Kazakova G, Safronova T, Golubchikov D, Shevtsova O, Rau J
Materials (Basel). 2021; 14(17).
PMID: 34500951
PMC: 8432688.
DOI: 10.3390/ma14174857.
Insights into the Cellular and Molecular Mechanisms That Govern the Fracture-Healing Process: A Narrative Review.
Papachristou D, Georgopoulos S, Giannoudis P, Panagiotopoulos E
J Clin Med. 2021; 10(16).
PMID: 34441849
PMC: 8397080.
DOI: 10.3390/jcm10163554.